BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, May 14, 2024
Home
»
Newsletters
» BioWorld
BioWorld
July 19, 2007
View Archived Issues
Neurochem Gets 2nd Approvable For Kiacta; Analysts Pessimistic
Almost a year after Neurochem Inc. received its first approvable letter for Kiacta (eprodisate) in the treatment of AA amyloidosis, history repeated itself. (BioWorld Today)
Read More
Preparing For AzaSite Launch, Inspire Gets $75M Investment
Read More
Edison, Penwest Enter Deal On Orphan Neurological Disorders
Read More
Clinical Data Boost Vilazodone Work With $66M Public Offering
Read More
Orchestra Dumps HIV Program After Vaccine Candidate Fails
Read More
Appointments And Advancements
Read More
Other News To Note
Read More
Clinic Roundup
Read More